Chronic Herpes Simplex Scleritis: Characterization of 9 Cases of an Underrecognized Clinical Entity

American Journal of Ophthalmology

Volumn 148, Issue 5, 2009, Pages

  Bhat, Pooja V ^a,b   Jakobiec, Frederick A ^a,b   Kurbanyan, Kristina ^b   Zhao, Tongzhen ^c   Foster, C Stephen ^b,c  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; CELECOXIB; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; ELECTROLYTE; INFLIXIMAB; LYSOZYME; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CHRONIC HERPES SIMPLEX SCLERITIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG DOSE REDUCTION; EYE EDEMA; EYE INFLAMMATION; EYE PAIN; FEMALE; GRANULOMATOUS INFLAMMATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INTERSTITIUM; MALE; PRIORITY JOURNAL; PSORIASIS; PYOGENIC GRANULOMA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SARCOIDOSIS; SCLERA; SCLERITIS; SERODIAGNOSIS; SYSTEMIC THERAPY; TREATMENT RESPONSE; VARICELLA ZOSTER VIRUS; VISUAL ACUITY;

EID: 70350575171     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.06.025     Document Type: Article

References (48)

1. Okhravi N., Odufuwa B., McCluskey P., and Lightman S. Scleritis. Surv Ophthalmol 50 (2005) 351-363
2. Watson P.G., and Hayreh S.S. Scleritis and episcleritis. Br J Ophthalmol 60 (1976) 163-191
3. Foster C.S., and Sainz de la Maza M. Diagnostic approach to episcleritis and scleritis. In: Foster C.S., and Sainz de la Maza M. (Eds). The Sclera (1994), Springer-Verlag, New York, New York 59-94
4. Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. Ocular complications of scleritis. In: Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. (Eds). The Sclera and Systemic Disorders (2004), Butterworth-Heinemann, London, England 121-138
5. Schwam B.L., and Raizman M.B. Scleritis. In: Krachmer J. (Ed). Cornea: Fundamentals of Diagnosis and Management (2003), Elsevier, London, England 1479-1492
6. Rao N.A., Marak G.E., and Hidayat A.A. Necrotizing scleritis. A clinico-pathologic study of 41 cases. Ophthalmology 92 (1985) 1542-1549
7. Hemady R., Sainz de la Maza M., Raizman M.B., and Foster C.S. Six cases of scleritis associated with systemic infection. Am J Ophthalmol 114 (1992) 55-62
8. Toma H.S., Murina A.T., Areaux Jr. R.G., et al. Ocular HSV-1 latency, reactivation, and recurrent disease. Semin Ophthalmol 23 (2008) 249-273
9. Kaye S., and Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 25 (2006) 355-380
10. Sundmacher R., and Neumann-Haefelin D. [Herpes simplex virus isolations from the aqueous humor of patients suffering from focal iritis, endotheliitis, and prolonged disciform keratitis with glaucoma (author's transl)]. Klin Monatsbl Augenheilkd 175 (1979) 488-501
11. Zamir E. Herpetic posterior uveitis. Int Ophthalmol Clin 45 (2005) 89-97
12. Pavan-Langston D., and Brockhurst R.J. Herpes simplex panuveitis. A clinical report. Arch Ophthalmol 81 (1969) 783-787
13. Cordero-Coma M., Anzaar F., Yilmaz T., and Foster C.S. Herpetic retinitis. Herpes 14 (2007) 4-10
14. Fisher J.P., Lewis M.L., Blumenkranz M., et al. The acute retinal necrosis syndrome. Part 1: clinical manifestations. Ophthalmology 89 (1982) 1309-1316
15. Cibis G.W., Flynn J.T., and Davis E.B. Herpes simplex retinitis. Arch Ophthalmol 96 (1978) 299-302
16. Egerer I., and Stary A. Erosive-ulcerative herpes simplex blepharitis. Arch Ophthalmol 98 (1980) 1760-1763
17. Jakobiec F.A., Srinivasan B.D., and Gamboa E.T. Recurrent herpetic angular blepharitis in an adult. Am J Ophthalmol 88 (1979) 744-747
18. Bustos D.E., and Atherton S.S. Detection of herpes simplex virus type 1 in human ciliary ganglia. Invest Ophthalmol Vis Sci 43 (2002) 2244-2249
19. Michel S., and Foster C.S. Definition, classification, etiology, and epidemiology. In: Foster C.S., and Vitale A.T. (Eds). Diagnosis and Treatment of Uveitis (2002), W. B. Saunders, Philadelphia, Pennsylvania 17-26
20. Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. Clinical presentation of scleritis and episcleritis. In: Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. (Eds). The Sclera and Systemic Disorders (2004), Butterworth-Heinemann, London, England 59-90
21. Foster C.S., and Sainz de la Maza M. Infectious scleritis: The Massachusetts Eye and Ear Experience. In: Foster C.S., and Sainz de la Maza M. (Eds). The Sclera (1994), Springer-Verlag, New York, New York 242-277
22. Smith J.S., and Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186 (2002) S3-S28
23. Verjans G.M., Hintzen R.Q., van Dun J.M., et al. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A 104 (2007) 3496-3501
24. Whitley R.J., Kimberlin D.W., and Roizman B. Herpes simplex viruses. Clin Infect Dis 26 (1998) 541-553 quiz 554-555
25. Schwam B.L., and Raizman M.B. Scleritis. In: Krachmer J. (Ed). Cornea and External Disease: Clinical Diagnosis and Management (1997), Mosby, St Louis, Missouri 1479-1491
26. Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. Scleral disease in relation to other systemic disorders. In: Watson P.G., Hazleman B.L., Pavesio C.E., and Green W.R. (Eds). The Sclera and Systemic Disorders (2004), Butterworth-Heinemann, London, England 213-247
27. Liesegang T.J. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 98 (1991) 1216-1229
28. Afshari N.A., Afshari M.A., and Foster C.S. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep 3 (2001) 453-458
29. McGavin D.D., Williamson J., Forrester J.V., et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60 (1976) 192-226
30. Bullen C.L., Liesegang T.J., McDonald T.J., and DeRemee R.A. Ocular complications of Wegener's granulomatosis. Ophthalmology 90 (1983) 279-290
31. Harper S.L., Letko E., Samson C.M., et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol 28 (2001) 1025-1032
32. Ahmed M., Niffenegger J.H., Jakobiec F.A., et al. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol 28 (2008) 35-46
33. Isaak B.L., Liesegang T.J., and Michet Jr. C.J. Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93 (1986) 681-689
34. Tuft S.J., and Watson P.G. Progression of scleral disease. Ophthalmology 98 (1991) 467-471
35. Foster C.S. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology 87 (1980) 140-150
36. Sainz de la Maza M., and Foster C.S. Necrotizing scleritis after ocular surgery. A clinicopathologic study. Ophthalmology 98 (1991) 1720-1726
37. Salacz G. Postoperative necrotizing sclerokeratitis. Doc Ophthalmol 80 (1992) 167-170
38. O'Donoghue E., Lightman S., Tuft S., and Watson P. Surgically induced necrotising sclerokeratitis (SINS)-precipitating factors and response to treatment. Br J Ophthalmol 76 (1992) 17-21
39. Helm C.J., Holland G.N., Webster Jr. R.G., Maloney R.K., and Mondino B.J. Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis. Ophthalmology 104 (1997) 838-843
40. Schonherr U., Naumann G.O., Lang G.K., and Bialasiewicz A.A. Sclerokeratitis caused by Mycobacterium marinum. Am J Ophthalmol 108 (1989) 607-608
41. Liesegang T.J., and Cameron J.D. Mycobacterium bovis infection of the conjunctiva. Arch Ophthalmol 98 (1980) 1764-1766
42. Wilhelmus K.R., and Yokoyama C.M. Syphilitic episcleritis and scleritis. Am J Ophthalmol 104 (1987) 595-597
43. Fincher T., and Fulcher S.F. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis. Cornea 26 (2007) 618-620
44. Foster C.S., and Barney N.P. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 80 (1992) 363-369
45. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001) 1-13
46. Goldberg L.H., Kaufman R., Kurtz T.O., et al., Acyclovir Study Group. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Arch Dermatol 129 (1993) 582-587
47. Wilhelmus K.R., Beck R.W., Moke P.S., et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 339 (1998) 300-306
48. Uchoa U.B., Rezende R.A., Carrasco M.A., Rapuano C.J., Laibson P.R., and Cohen E.J. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol 121 (2003) 1702-1704